Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives are: - To evaluate clinical remission for the 2 SC maintenance regimens of ustekinumab in subjects with moderately to severely active Crohn’s disease induced into clinical response with ustekinumab in the induction studies, CNTO1275CRD3001 and CNTO1275CRD3002. - To evaluate the safety of 2 SC maintenance regimens of ustekinumab in subjects with moderately to severely active Crohn’s disease.
Inclusion criteria
- Moderately-to-Severely Active Crohn’s Disease